Mersana Therapeutics News

Mersana Therapeutics Analyst Ratings

BenzingaMar 19 05:49 ET

Mersana Therapeutics (MRSN) Gets a Buy From Truist Financial

TipRanksMar 12 08:37 ET

Buy Rating Affirmed for Mersana Therapeutics Amid Promising ADC Developments and Upcoming Milestones

TipRanksMar 1 01:07 ET

Mersana Therapeutics Analyst Ratings

BenzingaFeb 29 10:49 ET

TD Cowen Sticks to Its Buy Rating for Mersana Therapeutics (MRSN)

TipRanksFeb 28 12:55 ET

Mersana Therapeutics: A Cautious Hold Amid Clinical and Strategic Uncertainties

TipRanksJan 9 01:07 ET

BTIG Sticks to Their Hold Rating for Mersana Therapeutics (MRSN)

TipRanksJan 2 09:34 ET

Citigroup Upgrades Mersana Therapeutics to Buy, Raises Price Target to $5

BenzingaDec 4, 2023 11:16 ET

Mersana Therapeutics Analyst Ratings

BenzingaDec 4, 2023 11:13 ET

Hold Rating on Mersana Therapeutics Amidst Clinical Trial Progress and Solid Financial Position

TipRanksNov 10, 2023 06:06 ET

Analysts Offer Insights on Healthcare Companies: CymaBay Therapeutics (CBAY), Mersana Therapeutics (MRSN) and Verona Pharma (VRNA)

TipRanksNov 8, 2023 06:41 ET

Mersana Therapeutics (MRSN) Gets a Hold From BTIG

TipRanksNov 8, 2023 01:18 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Mersana Therapeutics (MRSN) and Crispr Therapeutics AG (CRSP)

TipRanksNov 1, 2023 06:12 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Mersana Therapeutics (MRSN), Applied Therapeutics (APLT) and Align Tech (ALGN)

TipRanksSep 8, 2023 02:22 ET

Mersana Therapeutics (MRSN) Receives a Hold From Truist Financial

TipRanksSep 6, 2023 22:25 ET

Mersana Therapeutics (MRSN) Gets a Hold From Robert W. Baird

TipRanksAug 11, 2023 12:15 ET

Analysts Conflicted on These Healthcare Names: Laboratory (LH), Hologic (HOLX) and Mersana Therapeutics (MRSN)

TipRanksAug 3, 2023 08:11 ET

Mersana Downgraded at Baird as Ovarian Cancer Candidate Misses Mark

Seeking AlphaJul 28, 2023 12:31 ET

Citigroup Downgrades Mersana Therapeutics to Neutral, Lowers Price Target to $1

BenzingaJul 28, 2023 09:17 ET

Analysts Conflicted on These Healthcare Names: Baxter International (BAX), Mersana Therapeutics (MRSN) and Acadia Healthcare (ACHC)

TipRanksJul 28, 2023 06:30 ET